Ovarian Cancer: Racial & Ethnic Survival Disparities
Despite a decline in overall ovarian cancer mortality, disparities persist across racial adn ethnic groups, demanding immediate attention. This article dives into recent findings revealing important differences in ovarian cancer survival, particularly within Asian American subgroups. Explore how data from 1999 to 2020 shows that, while progress has been made, non-hispanic White and Black patients still face higher mortality rates. Discover the critical need for tailored approaches to improve ovarian cancer outcomes, focusing on early detection and culturally sensitive care. For a deeper understanding, News Directory 3 has the scoop, and researchers highlight the urgent need for interventions. What further insights await us in the quest to eliminate these disparities? Discover what’s next.
Ovarian Cancer: Racial, Ethnic Disparities Persist Despite Mortality decline
updated May 27, 2025
While overall ovarian cancer mortality has declined in the United States, significant disparities persist among racial and ethnic subgroups, particularly within the Asian American, Native Hawaiian, and Pacific Islander populations. These findings, drawn from abstracts released ahead of the 2025 American Society of Clinical Oncology Annual Meeting, highlight the critical need for targeted interventions.
A study analyzing data from 1999 to 2020 revealed that while ovarian cancer mortality decreased from 9.48 per 100,000 individuals in 1999 to 6.55 in 2020,substantial racial disparities remain. Non-hispanic White patients experienced the highest mortality rates, followed by non-Hispanic Black patients. The research underscores the importance of addressing these disparities to improve ovarian cancer survival outcomes.
Another abstract focused on Asian American, Native Hawaiian, and Pacific Islander populations, revealing that aggregating these groups masks significant differences. While, as a whole, these populations showed better survival rates than non-hispanic White patients, disaggregated data exposed disparities. East Asian patients had better survival rates compared to Southeast Asian and Native Hawaiian/Pacific Islander patients, indicating the need for tailored approaches within these communities to combat ovarian cancer.
The research team used data from the CDC and the National Cancer Database to conduct thier analyses. The CDC data spanned from 1999 to 2020, while the national Cancer database included patients diagnosed between 2004 and 2022.
Age also plays a role, with individuals aged 65 and older experiencing the highest mortality rates.Geographically, rates were relatively consistent across regions and between metropolitan and non-metropolitan areas.
“Targeted strategies are needed to further prevent mortality from ovarian cancer in high-risk groups,especially dealing with the racial disparities,” the authors wrote.
What’s next
Further research and targeted interventions are crucial to address the disparities in ovarian cancer mortality and improve outcomes for all populations, particularly within vulnerable racial and ethnic subgroups. These efforts should focus on early detection,access to care,and culturally sensitive approaches.